Rosetta Genomics Ltd.
DelistedCIK 1362959fmd_109F2Q3WW22MKJ1G83JP565FWAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2017, 15 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 2 |
| Cost of revenue | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 2 |
| Gross profit | 0 | (0) | (0) | (0) | (0) | 0 | 2 | 0 |
| Research and development | 7 | 6 | 3 | 1 | 2 | 2 | 3 | 3 |
| Selling, general and administrative | 8 | 7 | 5 | 7 | 11 | 12 | 12 | 10 |
| Total operating expenses | 15 | 14 | 9 | 8 | 13 | 14 | 15 | 13 |
| Operating income | 15 | (14) | (9) | (8) | (13) | (14) | (13) | (13) |
| Interest expense | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | 1 | (2) | 0 | (0) | (2) | (1) |
| Income before taxes | – | – | – | (11) | (13) | (15) | (15) | (13) |
| Income tax expense | – | – | – | – | – | 0 | 0 | (0) |
| Net income from continuing operations | (15) | (13) | (7) | (11) | (13) | (15) | (15) | (13) |
| Net income | 17 | (15) | (9) | (10) | (13) | (15) | (17) | (16) |